Evidence map›Paper›PMID 34635511›Full record

Trial reportBMJ open2021

FullFix: a randomised controlled trial of a telephone delivered transdiagnostic intervention for comorbid substance and mental health problems in young people.

Zoe Walter, Catherine A Quinn, Genevieve Dingle, Nina Pocuca, Amanda L Baker, Alison Beck, Dominique De Andrade, Maree Toombs, Leanne Hides

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Impact of warm mindfulness on emotion regulation: A randomized controlled effectiveness trial.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2023
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zoe WalterSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia z.walter@uq.edu.au.ORCID 0000-0001-8310-4021
Catherine A QuinnSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
Genevieve DingleSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
Nina PocucaSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0003-0264-1680
Amanda L BakerSchool of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
Alison BeckSchool of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
Dominique De AndradeSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
Maree ToombsRural Clinical School, The University of Queensland, Toowoomba, Queensland, Australia.
Leanne HidesSchool of Psychology, The University of Queensland, Brisbane, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTransdiagnostic cognitive-behavioural therapy (CBT) targets common psychological factors that underlie multiple disorders. While transdiagnostic interventions are a promising new approach, limited research has evaluated these treatments within the alcohol and other drug (AOD) sector for young people with comorbid mental health symptoms. This project will examine the feasibility and preliminary efficacy of FullFix-a new risk-targeted transdiagnostic CBT telehealth programme for comorbid AOD and depression/anxiety disorders in young people. Secondary aims are to identify moderators and mediators of treatment outcomes, to determine how and why treatment is effective and who is most likely to benefit. METHODS/

designParticipants will be 130 young people (aged 16-35) accessing AOD services in Queensland, Australia, with comorbid mental health symptoms. They will be randomised to receive either the FullFix intervention plus standard AOD care or standard AOD care alone. Primary outcomes on AOD use and mental health symptoms will be reassessed at 6 weeks, 3 months, 6 months and 12 months, along with secondary outcomes of emotion regulation, social connectedness, perceived self-efficacy, coping skills and quality of life. The trial commenced on October 2018 and expected completion date is September 2021. ETHICS AND DISSEMINATION: Ethical approval for this trial was provided by the University of Queensland (#2018001185). The results of the trial will be disseminated through publication in a peer-reviewed scientific journal, scientific presentations at conferences and distributed via a report and presentations to the partner organisation. TRIAL REGISTRATION NUMBER: ACTRN12618001563257.

Indexed as

Cognitive Behavioral TherapyMental HealthAdolescentCost-Benefit AnalysisHumansQuality of LifeTelephonemental healthsubstance misusetelemedicine

Identifiers

PMID34635511
PMCPMC8506879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.